Neuromod Tools

Lenire is a bimodal neuromodulation device which functions by delivering light electric pulses to the tongue, through an intra-oral element called the 'Tonguetip ®', incorporated with auditory stimulation with earphones to drive lasting adjustments in the brain to deal with tinnitus.

Founded in 2010 by Dr. Ross 'Neill, CHIEF EXECUTIVE OFFICER, Neuromod Devices is a clinical innovation business that specialises in the layout and growth of neuromodulation modern technologies to address the medical needs of underserved individual populaces that deal with chronic and devastating problems.

Because the previous round of moneying raised in October 2020, the firm has actually made progression commercialising Lenire, broadening the tool's availability throughout Europe, establishing a completely owned United States subsidiary, neuromod devices wirbt 30 millionen euro ein USA Inc, and safeguarding United States market approval from the FDA.

The very first of these tests, TENT-A1, represents one of the biggest and lengthiest followed-up medical tests ever before conducted in the tinnitus field and was the cover story for the scientific journal Science Translational Medicine in October 2020.